American Shared Hospital Services (NYSEAMERICAN:AMS) Stock Passes Above 200 Day Moving Average – Time to Sell?

American Shared Hospital Services (NYSEAMERICAN:AMS) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $2.83. American Shared Hospital Services shares last traded at $2.83, with a volume of 2,504 shares.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on American Shared Hospital Services in a research note on Tuesday, January 14th. They issued a “hold” rating on the stock.

American Shared Hospital Services Stock Performance

The company has a market cap of $17.98 million, a P/E ratio of 4.67 and a beta of 0.66. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.46 and a current ratio of 1.46.

Institutional Investors Weigh In On American Shared Hospital Services

A hedge fund recently raised its stake in American Shared Hospital Services stock. Renaissance Technologies LLC boosted its position in American Shared Hospital Services (NYSEAMERICAN:AMS) by 5.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,225 shares of the company’s stock after buying an additional 3,776 shares during the quarter. Renaissance Technologies LLC owned approximately 1.11% of American Shared Hospital Services worth $227,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 23.16% of the stock is owned by institutional investors.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.